Challenges in diagnosing and monitoring diabetes in patients with chronic liver diseases.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Diabetes & metabolic syndrome

• Publication date

  2017-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.dsx.2017.12.013PMID 29279271
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Significant disparities in risks of diabetes mellitus and metabolic syndrome among chronic hepatitis C virus patients in the U.S.

  2017cited by this paper
• Hepatogenous diabetes: Is it time to separate it from type 2 diabetes?

  2017cited by this paper
• The epidemiology of non‐alcoholic fatty liver disease

  2017cited by this paper
• Glycated albumin: from biochemistry and laboratory medicine to clinical practice

  2017cited by this paper
• Evidence for current diagnostic criteria of diabetes mellitus.

  2016cited by this paper
• Current level of evidence on causal association between hepatitis C virus and type 2 diabetes: A review

  2016cited by this paper
• Association between hepatitis B and metabolic syndrome: Current state of the art.

  2016cited by this paper
• The Origin of New-Onset Diabetes After Liver Transplantation: Liver, Islets, or Gut?

  2016cited by this paper
• Endocrine dysfunction in hereditary hemochromatosis

  2016cited by this paper
• Re-evaluation of glycated hemoglobin and glycated albumin with continuous glucose monitoring system as markers of glycemia in patients with liver cirrhosis

  2016cited by this paper
• Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015.

  2016cited by this paper
• Glycated Hemoglobin Levels in Patients with Decompensated Cirrhosis

  2016cited by this paper
• Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participants

  2016cited by this paper
• Hepatitis C Virus, Insulin Resistance, and Steatosis

  2016cited by this paper
• Interferences and Limitations in Blood Glucose Self-Testing

  2016cited by this paper
• Risk Factors for Insulin Resistance, Metabolic Syndrome, and Diabetes in 248 HFE C282Y Homozygotes Identified by Population Screening in the HEIRS Study

  2016cited by this paper
• Non-alcoholic fatty liver disease and risk of type 2 diabetes.

  2016cited by this paper
• Utility of Continuous Glucose Monitoring in Type 1 and Type 2 Diabetes.

  2016cited by this paper
• Metabolic complications in liver transplant recipients.

  2016cited by this paper
• Diabetes mellitus in patients with cirrhosis: clinical implications and management

  2016cited by this paper
• Diagnosis and Management of Diabetes: Synopsis of the 2016 American Diabetes Association Standards of Medical Care in Diabetes

  2016cited by this paper
• Glycated albumin as a diagnostic tool for diabetes in a general Japanese population.

  2015cited by this paper
• Standards of Medical Care in Diabetes—2016: Summary of Revisions

  2015cited by this paper
• Genetics, Genetic Testing, and Management of Hemochromatosis: 15 Years Since Hepcidin.

  2015cited by this paper
• New‐onset diabetes after liver transplantation and its impact on complications and patient survival

  2015cited by this paper
• Alternative biomarkers for assessing glycemic control in diabetes: fructosamine, glycated albumin, and 1,5-anhydroglucitol

  2015cited by this paper
• Advantages and Pitfalls of Fructosamine and Glycated Albumin in the Diagnosis and Treatment of Diabetes

  2015cited by this paper
• Diabetes and Hepatitis C: A Two-Way Association

  2015cited by this paper
• Genetic variation in transmembrane 6 superfamily member 2 and the risk of nonalcoholic fatty liver disease and histological disease severity

  2015cited by this paper
• Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis

  2014cited by this paper
• Diabetes and Hemochromatosis

  2014cited by this paper
• Abdominal subcutaneous adipose tissue insulin resistance and lipolysis in patients with non-alcoholic steatohepatitis

  2014cited by this paper
• The global burden of liver disease: a challenge for methods and for public health

  2014cited by this paper
• Nowy rok, stare problemy, ale i nowe możliwości

  2014cited by this paper
• 1,5-Anhydroglucitol and glycated albumin in glycemia.

  2014cited by this paper
• Pitfalls in Hemoglobin A1c Measurement: When Results may be Misleading

  2014cited by this paper
• Hepatitis C virus infection and insulin resistance.

  2014cited by this paper
• Diabetes mellitus is an independent prognostic factor for major liver‐related outcomes in patients with cirrhosis and chronic hepatitis C

  2014cited by this paper
• Global epidemiology and genotype distribution of the hepatitis C virus infection.

  2014cited by this paper
• Hepatic energy metabolism in human diabetes mellitus, obesity and non-alcoholic fatty liver disease.

  2013cited by this paper
• Cohort Study of Non-alcoholic Fatty Liver Disease, NAFLD fibrosis score, and the Risk of Incident Diabetes in a Korean population

  2013cited by this paper
• Clinical availability of nonalcoholic fatty liver disease as an early predictor of type 2 diabetes mellitus in korean men: 5‐year prospective cohort study

  2013cited by this paper
• Influence of non‐alcoholic fatty liver disease on the development of diabetes mellitus

  2013cited by this paper
• Phenotypic and clinical manifestations of compound heterozygous genetic haemochromatosis (CHGH): a non‐invasive approach to clinical management

  2013cited by this paper
• Association between donor and recipient TCF7L2 gene polymorphisms and the risk of new-onset diabetes mellitus after liver transplantation in a Han Chinese population.

  2013cited by this paper
• 1,5-Anhydroglucitol in diabetes mellitus

  2013cited by this paper
• Haemoglobin A1c: Historical overview and current concepts.

  2013cited by this paper
• Calcineurin inhibition and new-onset diabetes mellitus after transplantation.

  2013cited by this paper
• Incidence and risk factors for new‐onset diabetes in living‐donor liver transplant recipients

  2013cited by this paper
• Lipotoxicity disrupts incretin-regulated human β cell connectivity.

  2013cited by this paper
• Diabetes in First-Degree Family Members: A Predictor of Type 2 Diabetes in 159 Nonscreening Alabama Hemochromatosis Probands With HFE C282Y Homozygosity

  2013cited by this paper
• Monitoring glycemic control.

  2013cited by this paper
• Prevalence of Prediabetes and Diabetes and Metabolic Profile of Patients With Nonalcoholic Fatty Liver Disease (NAFLD)

  2012cited by this paper
• Glycated albumin in diabetic patients with chronic kidney disease.

  2012cited by this paper
• Hepatitis C Virus Activates the mTOR/S6K1 Signaling Pathway in Inhibiting IRS-1 Function for Insulin Resistance

  2012cited by this paper
• GlucoMen Day Continuous Glucose Monitoring System: A Screening for Enzymatic and Electrochemical Interferents

  2012cited by this paper
• Changes of gut bacteria and immune parameters in liver transplant recipients.

  2012cited by this paper
• Incidence and predictors of 30-day readmission among patients hospitalized for advanced liver disease.

  2011cited by this paper
• Influence of non-alcoholic fatty liver disease on the development of diabetes mellitus: results from a prospective, community based, cohort study

  2011cited by this paper
• The impact of diabetes mellitus in mortality of patients with compensated liver cirrhosis-a prospective study.

  2011cited by this paper
• Non-HFE Hepatic Iron Overload

  2011cited by this paper
• Relationship between hepatitis C virus recurrence and de novo diabetes after liver transplantation: the Hungarian experience.

  2011cited by this paper
• Utility of glycated albumin for the diagnosis of diabetes mellitus in a Japanese population study: results from the Kyushu and Okinawa Population Study (KOPS)

  2011cited by this paper
• Unique Cellular and Mitochondrial Defects Mediate FK506-Induced Islet &bgr;-Cell Dysfunction

  2011cited by this paper
• The glycation of albumin: structural and functional impacts.

  2011cited by this paper
• Serum glycated albumin, but not glycated hemoglobin, is low in relation to glycemia in men with hypertriglyceridemia

  2010cited by this paper
• Difficulties in interpreting HbA(1c) results.

  2010cited by this paper
• Self-Monitoring of Blood Glucose: Practical Aspects

  2010cited by this paper
• HbA1c and factors other than diabetes mellitus affecting it.

  2010cited by this paper
• Effect of iron overload on glucose metabolism in patients with hereditary hemochromatosis.

  2010cited by this paper
• Standards of Medical Care in Diabetes—2010

  2010cited by this paper
• Serum Dipeptidyl Peptidase-4 Activity in Insulin Resistant Patients with Non-Alcoholic Fatty Liver Disease: A Novel Liver Disease Biomarker

  2010cited by this paper
• Technologies for Continuous Glucose Monitoring: Current Problems and Future Promises

  2010cited by this paper
• Hepatitis C Virus Differentially Modulates Activation of Forkhead Transcription Factors and Insulin-Induced Metabolic Gene Expression

  2010cited by this paper
• Serum glycated albumin levels, but not glycated hemoglobin, is low in relation to glycemia in non-diabetic men with nonalcoholic fatty liver disease with high alanine aminotransferase levels.

  2010cited by this paper
• Fatty liver and lipotoxicity.

  2010cited by this paper
• Serum glycated albumin, but not glycated haemoglobin, is low in relation to glycemia in hyperuricemic men

  2010cited by this paper
• High prevalence of diabetes mellitus in patients with liver cirrhosis

  2010cited by this paper
• COMPARISON OF GLYCATED ALBUMIN AND HEMOGLOBIN A1c CONCENTRATIONS IN DIABETIC SUBJECTS ON PERITONEAL AND HEMODIALYSIS

  2010cited by this paper
• International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes

  2009cited by this paper
• The Clinical Use of Hemoglobin A1c

  2009cited by this paper
• Atualização sobre hemoglobina glicada (HbA1C) para avaliação do controle glicêmico e para o diagnóstico do diabetes: aspectos clínicos e laboratoriais

  2009cited by this paper
• Sustained virological response reduces incidence of onset of type 2 diabetes in chronic hepatitis C

  2009cited by this paper
• A common genetic variant in WFS1 determines impaired glucagon-like peptide-1-induced insulin secretion

  2009cited by this paper
• Liver cirrhosis and diabetes: risk factors, pathophysiology, clinical implications and management.

  2009cited by this paper
• Falsely Low Hemoglobin A1c Levels in a Patient Receiving Ribavirin and Peginterferon alfa‐2b for Hepatitis C

  2009cited by this paper
• Association of Type 2 Diabetes Candidate Polymorphisms in KCNQ1 With Incretin and Insulin Secretion

  2009cited by this paper
• Association of serum glycated albumin to haemoglobin A1C ratio with hepatic function tests in patients with chronic liver disease

  2009cited by this paper
• HFE C282Y/H63D compound heterozygotes are at low risk of hemochromatosis‐related morbidity

  2009cited by this paper
• Familial association between type 1 diabetes and other autoimmune and related diseases

  2009cited by this paper
• Spectrum of anemia associated with chronic liver disease.

  2009cited by this paper
• International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes: Diabetes Care 2009; 32(7): 1327-1334.

  2009cited by this paper
• Effects of thyroid hormone on serum glycated albumin levels: study on non-diabetic subjects.

  2009cited by this paper
• Declining prevalence of diabetes mellitus in hereditary haemochromatosis--the result of earlier diagnosis.

  2008cited by this paper
• 1,5-anhydroglucitol (GlycoMark™) as a marker of short-term glycemic control and glycemic excursions

  2008cited by this paper
• Evidence of oxidative stress as a cofactor in the development of insulin resistance in patients with chronic hepatitis C

  2008cited by this paper
• Reappraisal of the Characteristics of Glucose Abnormalities in Patients With Chronic Hepatitis C Infection

  2008cited by this paper
• CLD (chronic liver diseases)-HbA1C as a suitable indicator for estimation of mean plasma glucose in patients with chronic liver diseases.

  2008cited by this paper
• Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease

  2008cited by this paper
• Prevalence of metabolic syndrome, obesity and diabetes type 2 in cryptogenic cirrhosis.

  2008cited by this paper

• Assessment of Glecaprevir/Pibrentasvir Treatment’s Influence on Biochemical and Metabolic Markers in Patients with Chronic Hepatitis

  2024cites this paper
• The First Case of Intraportal Islet Implantation During Liver Machine Perfusion Allowing Simultaneous Islet-liver Transplantation in a Human - A New and Safe Treatment for End-stage Liver Disease Combined With Diabetes Mellitus

  2024cites this paper
• Impact of Donor Age on Liver Transplant Outcomes in Patients with Acute-on-Chronic Liver Failure: A Cohort Study

  2024cites this paper
• Intermittently Scanned Continuous Glucose Monitoring Performance in Patients With Liver Cirrhosis

  2024cites this paper
• 3D Printed Hydrogel Microneedle Arrays for Interstitial Fluid Biomarker Extraction and Colorimetric Detection

  2023cites this paper
• Characterization of glucose metabolism in youth with vs. without cystic fibrosis liver disease: A pilot study

  2022cites this paper
• Colorimetric microneedle patches for multiplexed transdermal detection of metabolites.

  2022cites this paper
• Flash glucose monitoring system in special situations

  2022cites this paper
• Aktualisierte S2k-Leitlinie nicht-alkoholische Fettlebererkrankung der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – April 2022 – AWMF-Registernummer: 021–025

  2022cites this paper
• Effect of type 2 diabetic mellitus in the prognosis of acute-on-chronic liver failure patients in China

  2021cites this paper
• Detecting dysglycaemia in compensated liver cirrhosis: Comparison of oral glucose tolerance test and glycated haemoglobin, with continuous glucose monitoring

  2021cites this paper
• Role of Flash Glucose Monitoring System in Diabetic Patients with Chronic Liver Disease

  2021cites this paper
• Clinical Performance of Flash Glucose Monitoring System in Patients with Liver Cirrhosis and Diabetes Mellitus

  2020cites this paper
• Peri-transplant management of nonalcoholic fatty liver disease in liver transplant candidates .

  2020cites this paper
• Review of Methods for Detecting Glycemic Disorders.

  2020cites this paper
• Management of Diabetes Mellitus in Patients with Chronic Liver Diseases

  2019cites this paper
• Diabetes Mellitus Data Classification by Cascading of Feature Selection Methods and Ensemble Learning Algorithms

  2018cites this paper